ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1879

Work Related Injuries Causing or Aggravating Fibromyalgia in the Medicolegal Arena: A Jurisprudential Analysis

Mary-Ann Fitzcharles1, Peter A. Ste-Marie2 and Yoram Shir3, 1Rheumatology and Pain Management Unit, McGill University Health Centre, Montreal, QC, Canada, 2University of Montreal, Montreal, QC, Canada, 3Alan Edwards Pain Management Unit, McGill University Health Centre, Montreal, QC, Canada

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: fibromyalgia

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Fibromyalgia and Soft Tissue Disorders

Session Type: Abstract Submissions (ACR)

Background/Purpose: Up to 40% of persons report onset of fibromyalgia (FM) following a “triggering event”. Injuries, which may occur in the workplace, may be implicated in some, hence linking FM to compensation. In Ontario, Canada, work injury causing physical abnormality is compensated according to the American Medical Association guides, with apportionment for pain, whereas injury without body changes, ie soft tissue, is compensated according to a chronic pain policy. FM, without tissue damage, falls under this policy. The Workplace Safety and Insurance Appeals Tribunal (WSIAT) is the final level of appeal for workers who request compensation for a work-related injury as causation for FM, with decisions available in the public domain.

Methods: Between June 2006 and December 2011, 150 Tribunal decisions relevant to FM were examined by predetermined search protocol. Twelve did not meet inclusion criteria; FM was not the central issue in 4, and 8 were for increased awards. New onset FM was appealed in 123, and aggravation of pre-existing FM in 15. Information in the aggravation cases was limited.

Results: All injuries were of a soft tissue nature, without any persistent physical findings to explain continued symptoms. Of the 15 cases pleading aggravation of FM (14 female, mean age 50 ± 8 years), 5 were manual, 3 clerical, 7 health care or education workers. Thirteen injuries were acute, 2 occurred gradually, with low back or neck identified in 13, and the Tribunal accepted 10/15 (67%). In the 123 new onset FM, (104 female, mean age 52 ± 9 years), 60 were manual, 29 clerical, 30 health care or education workers, 4 unknown, with 32% reporting repetitive work activity. Time from injury to diagnosis of FM (available for 117) was 4.3 ± 4.1 years, with 6.3 ± 2.8 physicians cited for each worker. Previous psychological illness, injuries, neck pain or back pain were recorded as present for 17%, 22%, 10%, and 13% respectively, whereas there was no statement of previous health status for 39%. Injuries were a single event in 68%, and gradual in 32%, with location of injury in low back for 44%, and shoulder/upper limb in 40%. The FM diagnosis was based on report by a rheumatologist in 74%, and family physician in 13%, with 73 (59%) appeals accepted by the Tribunal.

Conclusion: Over half of appeals for aggravation or causation of FM following a work related soft tissue injury were upheld by the Tribunal. Claimants were demographically similar to other FM cohorts, although healthcare utilization was very high. Low back and upper limb injuries predominated as causation, with over two thirds reporting FM following a single incident. The attribution of causation of FM to a single workplace traumatic event is contentious and requires further examination.


Disclosure:

M. A. Fitzcharles,

Pfizer Inc, Lilly, Purdue, Valeant,

5;

P. A. Ste-Marie,
None;

Y. Shir,

Astra-Zeneca, Janssen, Paladin, Pfize Inc, Purdue,

5.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/work-related-injuries-causing-or-aggravating-fibromyalgia-in-the-medicolegal-arena-a-jurisprudential-analysis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology